Navigation Links
Amilpar Acquires ESHO
Date:2/1/2010

RIO DE JANEIRO, Feb. 1 /PRNewswire-FirstCall/ -- Amil Participacoes S.A. (Bovespa: AMIL3) ("Amilpar"), in accordance with CVM (the Brazilian Securities and Exchange Commission) Instruction 358/02, informs that today it exercised the option to purchase 100% of ESHO - Empresa de Servicos Hospitalares Ltda, as established in the Management and Hospital Call Option Agreement, signed on October 18, 2007, in the total amount of R$ 60.1 million, set after the auditing process, according to the decision taken by Amilpar's Board of Directors, in a meeting held on November 9, 2009.

The payment will be made in 48 monthly and successive installments, adjusted by the CDI (average interbank deposit rate in Brazil), the first installment with maturity on February 18 and the other installments on the 15th day of each month.

The main assets that comprise ESHO are the three hospitals which were already managed by Amilpar, as established in the Management and Hospital Call Option Agreement, and this acquisition is the accomplishment of the compromise made by Amilpar at the time of its IPO. Hospital information:

(i) CardioTrauma Hospital, located at Rua Farme de Amoedo, Ipanema, in the city and state of Rio de Janeiro, has 46 beds;

(ii) Mario Lioni Hospital, located at Rua Ana Neri, Bairro Vinte e Cinco de Agosto, Duque de Caxias, in the state of Rio de Janeiro, has 120 beds;

(iii) Hospital Paulistano, located at Rua Martiniano de Carvalho, the corner with Rua Pio XII, Bairro Liberdade, in the city and state of Sao Paulo,
'/>"/>

SOURCE Amil Participacoes S.A.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Amilpar - Relevant Fact - Public Offer Result
2. Amilpar - Press Release
3. Amilpar - Distribution of Interest on Capital Stock
4. Amilpar - Relevant Fact
5. Amilpar - Press Release - Commercial Papers
6. Amilpar - Relevant Fact - Public Offer
7. Amilpar - Revenues Grow 8% and Net Income Improves 28% in 3Q09
8. Amilpar - Operating Revenues Grew 9% in the Second Quarter and 11% in the First Half of 2009
9. Amilpar - Revenue Increases 13.4% and Medical Loss Ratio Falls in the First Quarter 2009
10. Amilpar - Revenues Increase by 26.5% and Adjusted Net Income Climbs 28.7% in 2008
11. Amilpar - Notice to Shareholders - Distribution of Interest on Capital Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... NC (PRWEB) May 26, 2015 ... compliance solutions for the health and human services market, ... to meet demand. After strong attendance and participation in ... groups, and give their annual user conference an exciting ... Relias customers to come together and discuss best practices, ...
(Date:5/26/2015)... May 26, 2015 Mr. Larry Westenberg ... expert in Neuro-Linguistic Programming, or NLP. Mr. Westenberg ... Rapid Resolution Therapy® or RRT®. While many people ... and applied it to specific areas, Mr. Westenberg has ... for over 20 years. He works with people ...
(Date:5/26/2015)... Santa Rosa, CA (PRWEB) May 26, 2015 ... Management and Analytics solutions for more than 15 years, ... from the National Committee for Quality Assurance (NCQA) for ... today. , “We are proud of the work we ... years and are grateful for the acknowledgement from NCQA ...
(Date:5/26/2015)... Pass, OR (PRWEB) May 26, 2015 ... always fatal if not caught early. Melanoma is also ... water advocate Sharon Kleyne, the melanoma rate is on ... radiation. While the melanoma risk for indoor tanning salon ... these establishments. The most recent ban, in Pennsylvania, coincides ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Writers ... Editor with the Vasont® CCMS to make creating, ... Systems, a top component content management system (CCMS) ... (VUI) extension supports oXygen XML Editor Version 17.0, ... Vasont Universal Integrator extension merges key editorial functionality ...
Breaking Medicine News(10 mins):Health News:Relias Learning Expands User Groups and Industry Influence 2Health News:Relias Learning Expands User Groups and Industry Influence 3Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 2Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 3Health News:Skin Cancer Awareness Month: Pennsylvania Ban of Teens from Tanning Salons Is Praised by Fresh Water Advocate Sharon Kleyne 2Health News:Skin Cancer Awareness Month: Pennsylvania Ban of Teens from Tanning Salons Is Praised by Fresh Water Advocate Sharon Kleyne 3Health News:Vasont Systems Certifies the Integration between the Vasont® Component Content Management System and oXygen® XML Editor 17.0 2
... changes and inflammation has been awarded a Wellcome Trust ... The research programme at the National Institute for Health ... Professor Julian Davis, a consultant endocrinologist at Manchester Royal ... Biomedicine Research Group. He is working with Professor ...
... the Walter and Eliza Hall Institute in Melbourne, Australia, has ... further research into an aggressive and highly lethal form of ... the cell lining (epithelium) of the ovary, accounts for 90 ... still poorly understood, and recent research has revealed that it ...
... TUESDAY, Oct. 26 (HealthDay News) -- New research challenges previous ... with a certain genetic mutation. While guidelines have recommended ... their KRAS gene should not receive the targeted ... of these patients might actually benefit from taking the drug. ...
... , TUESDAY, Oct. 26 (HealthDay News) -- ... physicians, and this may be one reason for U.S. ... new study. Researchers looked at the wages of ... them into four broad categories: primary care; surgery; internal ...
... School of Medicine and The Children,s Hospital have taken a ... serious liver diseases in infants. The disease is called ... through which bile, crucial for digestion, flows to the small ... one in 10,000 births. But it,s life-threatening. "It ...
... In the 15 minutes a primary care doctor typically ... ailment, help manage ongoing health issues and provide preventive care. ... immediate mental health needs of patients is an ongoing challenge. ... Michigan Health System, however, points to an encouraging strategy for ...
Cached Medicine News:Health News:Manchester team wins $1.9 million grant for 'cell control' study 2Health News:VCA fellowship funding to extend ovarian cancer research 2Health News:New Insights on Who Should Take Erbitux for Colon Cancer 2Health News:Primary Care MDs at Low End of Pay Scale, Study Finds 2Health News:Breakthrough in understanding life-threatening childhood liver disease 2Health News:Follow-ups prove powerful tool for treating depression in primary care 2
(Date:5/26/2015)... , May 26, 2015  MGC Diagnostics Corporation (NasdaqCM: MGCD), ... to discuss its financial results for the second quarter of ... at 4:30 p.m. ET on Tuesday, June 2, 2015. The ... fiscal 2015 at the close of the markets on Tuesday, ... 317-6789 or (412) 317-6789 to access the conference call, or ...
(Date:5/26/2015)... Boehringer Ingelheim today announced that the ... STIOLTO™ RESPIMAT ® (tiotropium bromide and olodaterol) ... long-term, once-daily maintenance treatment of airflow obstruction in ... chronic bronchitis and/or emphysema. STIOLTO RESPIMAT is not ... COPD. COPD, which includes chronic bronchitis ...
(Date:5/26/2015)... 2015 Mast Therapeutics, Inc. ... its molecular adhesion and sealant technology (MAST) platform ... heart failure, and arterial disease, today reported that ... extension study of vepoloxamer (MST-188) in sickle cell ... enroll patients who have completed the Company,s Phase ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2015 Financial Results on Tuesday, June 2, 2015 2FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 2FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 3FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 4FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 5FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 6FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 7FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 8FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 9FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 10FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 11FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 12FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 13Mast Therapeutics Announces Initiation Of EPIC-E Study 2Mast Therapeutics Announces Initiation Of EPIC-E Study 3Mast Therapeutics Announces Initiation Of EPIC-E Study 4Mast Therapeutics Announces Initiation Of EPIC-E Study 5
... 15, 2011 Pharmaceutical companies are dramatically increasing ... meet the demands of a patient-empowered, data-driven, outcomes-focused ... alone, pharmaceutical company investment in smart phone apps, ... other programs increased 78%, as companies embrace a ...
... Unilife Corporation ("Unilife" or "Company") (Nasdaq: ... the three and six months ended December 31, 2010 (Fiscal ... Completed, on-schedule, the construction of a new ... staff now working out of the new facility ...
Cached Medicine Technology:Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 2Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 3Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 4Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 5Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 2Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 3Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 4Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 5Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 6Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 7
The flexible nature of the vinyl allows the user to reach deeper into the chamber and allows for a greater comfort when working inside the glove box over a long period of time compared to any rigid s...
This chamber is designed to provide a large workspace and gloveless dexterity in closed environment industrial, research and development, quality control packaging applications. Atmospheres of nitrog...
... MACS MICS is a fast, ... mixtures for growth of microaerophilic organisms.Designed ... jar-based MACS MICS runs at 1% ... envelopes and is suitable for growth ...
The airlock allows anaerobic entry of large flasks, vessels, and up to 90 plates at a time....
Medicine Products: